Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular Dysfunction

Duchenne muscular dystrophy (DMD) is characterized by myocardial fibrosis and left ventricular (LV) dysfunction. Implantable cardioverter defibrillator (ICD) use has not been characterized in this population but is considered for symptomatic patients with severe LV dysfunction (SLVD) receiving guide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric cardiology 2020-06, Vol.41 (5), p.925-931
Hauptverfasser: McCulloch, Michael A., Lal, Ashwin K., Knecht, Kenneth, Butts, Ryan J., Villa, Chet R., Johnson, Jonathan N., Conway, Jennifer, Bock, Matthew J., Schumacher, Kurt R., Law, Sabrina P., Friedland-Little, Joshua M., Deshpande, Shriprasad R., West, Shawn C., Lytrivi, Irene D., Gambetta, Katheryn E., Wittlieb-Weber, Carol A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Duchenne muscular dystrophy (DMD) is characterized by myocardial fibrosis and left ventricular (LV) dysfunction. Implantable cardioverter defibrillator (ICD) use has not been characterized in this population but is considered for symptomatic patients with severe LV dysfunction (SLVD) receiving guideline-directed medical therapy (GDMT). We evaluated ICD utilization and efficacy in patients with DMD. Retrospective cohort study of DMD patients from 17 centers across North America between January 2, 2005 and December 31, 2015. ICD use and its effect on survival were evaluated in patients with SLVD defined as ejection fraction (EF) 
ISSN:0172-0643
1432-1971
DOI:10.1007/s00246-020-02336-9